<DOC>
	<DOCNO>NCT01547754</DOCNO>
	<brief_summary>Background : - Some people human immunodeficiency virus ( HIV ) develop problem think concentration virus affect brain . This know mild neurocognitive disorder ( MND ) . Research show HIV medication get blood brain barrier well . P-glycoprotein ( P-gp ) brain protein part blood brain barrier . Differences activity P-gp may help explain people HIV develop MND . It also possible MND partly due inflammation brain . Researchers want study P-gp effect MND HIV infection . Objectives : - To study P-gp brain inflammation relate HIV infection . Eligibility : - Individuals 18 60 year age HIV either MND . - Healthy volunteer 18 60 year age . Design : - Participants screen medical history physical exam . Blood urine sample collect . - Participants one outpatient visit one 3-day inpatient stay . - At outpatient visit , participant provide blood sample lumbar puncture ( spinal tap ) . The spinal tap collect cerebrospinal fluid study . - At inpatient visit , participant two positron emission tomography ( PET ) scan brain . These scan study brain activity possible inflammation . One scan involve study drug call tariquidar , block activity P-gp . A second lumbar puncture do first PET scan . Blood urine sample collect daily .</brief_summary>
	<brief_title>Mild Neurocognitive Disorder HIV Infection Brain</brief_title>
	<detailed_description>Objective : To determine relationship among neuroinflammation , Permeability-glycoprotein ( P-gp ) function mild neurocognitive disorder ( MND ) , cognitive disorder associate HIV infection . Study Population : HIV seropositive subject MND , HIV seropositive subject normal cognitive function , HIV seronegative control subject . Design : Subjects undergo history physical exam , screen laboratory test , EKG , brain MRI neuropsychological evaluation . HIV-seropositive subject stratify base result neuropsychological evaluation HIV-seropositive control ( i.e. , cognitively normal ) HIV-seropositive MND . All subject receive brain PET image [ 11C ] dLop P-gp blockade measure function P-gp blood-brain barrier . P-gp block prior PET scan tariquidar . HIV-seropositive subject receive one lumbar puncture baseline one lumbar puncture P-gp blockade tariquidar measure CSF concentration anti-retroviral medication measure biomarkers blood-brain barrier integrity inflammation CSF . HIV-seronegative subject receive one lumbar puncture baseline measure biomarkers blood-brain barrier integrity inflammation CSF . Outcome Measures : The main outcome measure study brain uptake [ 11C ] dLop response P-gp blockade tariquidar . We correct individual metabolism tariquidar measure plasma concentration tariquidar P-gp block scan . As secondary outcome measure , concentration anti-retroviral medication CSF measure HIV seropositive subject without MND . CSF concentration use surrogate marker CNS delivery anti-retroviral drug .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Neurocognitive Disorders</mesh_term>
	<mesh_term>AIDS Dementia Complex</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Subjects must 18 60 year age . 2 . Capable provide informed consent . 3 . Ambulatory initial visit . 4 . Speak English fluently 5 . For HIV seropositive subject : 1 . Confirmation HIV antibody status ELISA Western Blot 2 . Documented HIVinfection least one year 3 . On stable antiretroviral regimen include protease inhibitor least 3 month viral load &lt; 400 copies/mL . 4 . Have primary care physician . Specific inclusion criterion mild neurocognitive disorder follow : 1 . Subject acquire mildtomoderate impairment cognitive function document score least 1 SD demographically correct norm test least two different cognitive domain . 2 . The cognitive impairment interferes , least mildly , activity daily live , determined neuropsychological interview . 3 . The impairment meet DSMIV criterion delirium dementia . 4 . The impairment fully explain comorbid condition . EXCLUSION CRITERIA : 1 . Current Axis I psychiatric illness severe systemic disease ( HIV MND ) base history physical exam would make study participation unsafe opinion investigator . 2 . Current alcohol use great 14 drink per week men 7 drink per week woman . 3 . Laboratory test clinically significant abnormality . Normal organ marrow function define : total leukocyte count great equal 3000 cells/ul , ANC great equal 1500 cells/ul , platelet count great equal 100,000 cells/ul , serum creatinine less equal 2.0 time upper limit normal , hemoglobin great equal 9.0 g/dL , serum calcium &lt; 12.0 mg/dL , AST/ALT le equal 1.5 time upper limit normal , PT 1.5 upper limit normal . 4 . EKG find consistent ischemic heart disease unless documentation normal cardiac function ( e.g. , normal stress test echocardiogram result ) . 5 . Previous research radiation exposure ( Xrays , PET scan etc . ) , study PET scan , would exceed annual research limit . 6 . Pregnancy breast feed . 7 . Evidence brain disease stroke , tumor , epilepsy , traumatic brain injury , neurodegenerative disease history screen MRI . 8 . Inability lay his/her back long period , severe claustrophobia , pacemaker , contraindication MRI . 9 . More moderate hypertension , define blood pressure great equal 160/95 time screen . 10 . Current use illicit drug base positive result urine screen illicit drug time screen . 11 . Subjects take medication , antiretroviral drug , know substrate Pgp safely discontinue study . Antiretroviral drug , particularly protease inhibitor ritonavir , Pgp substrates allow . Note : The rationale exclusion criterion alcohol use avoid alcoholrelated cognitive impairment confound factor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 25, 2014</verification_date>
	<keyword>Neuroinflammation</keyword>
	<keyword>HIV</keyword>
	<keyword>Positron Emission Tomograhy ( PET )</keyword>
	<keyword>Mild Neurocognitive Disorder</keyword>
	<keyword>P-Glycoprotein</keyword>
	<keyword>Mild Cognitive Disorder</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
</DOC>